Silvergate Pharmaceuticals Merges With CutisPharma To Serve Patients On Opposite Ends of the Spectrum
By: Colorado BioScience Association Date: 07/10/2019
Silvergate Pharmaceuticals produces pediatric medications, while CutisPharma has served the senior population. They’re bringing their companies together to form Azurity Pharmaceuticals. While it might...
Learn MoreCerapedics Announces Expansion of Colorado Headquarters
By: Colorado BioScience Association Date: 07/08/2019
WESTMINSTER, Colo., July 8, 2019 /PRNewswire/ -- Cerapedics, a private ortho-biologics company, today announced the expansion of the company's headquarters located in the Denver metropolitan area. Ove...
Learn MoreSeven Researchers Named Boettcher Investigators
By: Colorado BioScience Association Date: 05/28/2019
Newest Class Marks 10th Group Selected Under Webb-Waring Program Back row (l-r): Kara Mould, M. Cecilia Caino, Seonil Kim Front row (l-r): Neelanjan Mukherjee, Robert Dietz, Tara Cepon Robins Not pict...
Learn MoreArcherDX Announces Close of $60M Financing to Advance Companion Diagnostic and Minimal Residual Disease Monitoring Product Portfolio
By: Colorado BioScience Association Date: 05/15/2019
BOULDER, Colo., May, 15, 2019 /PRNEWSWIRE/-- ArcherDX, Inc., a molecular technology company dedicated to developing breakthrough solutions that advance the application of personalized genomic medicine...
Learn MorePrima-Temp Announces New Leadership, Investment, and CE Mark Certification
By: Colorado BioScience Association Date: 05/08/2019
BOULDER, Colo., May 3, 2019 /PRNewswire/ -- Boulder, Colorado based Prima-Temp, Inc. a developer and manufacturer of AI-assisted fertility management products, announced today that in March, it raised...
Learn MoreAdvaMed President and CEO Releases Statement On the House Bill To Repeal the Medical Device Tax
By: Colorado BioScience Association Date: 04/11/2019
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on introduction of bipartisan legislation (H.R. 2207) in t...
Learn MoreInscripta Completes $20M Expansion of Series C Financing, Increasing Total Round to $105.5M
By: Colorado BioScience Association Date: 04/08/2019
Inscripta, a leading gene editing technology company, today announced that it has increased its previously announced Series C financing with an additional $20 million from existing investors. The new...
Learn MoreColorado BioScience Association Applauds Expansion by Novartis Company AveXis to Longmont
By: Colorado BioScience Association Date: 04/01/2019
April 1, 2019 Background: AveXis, a Novartis company, announced the growth of its global advanced gene therapy manufacturing capacity with the acquisition of an advanced biologics therapy facility in...
Learn MoreDavid Perez Is Leaving Terumo BCT, But He'll Still Be Active In The Bioscience Community
By: Colorado BioScience Association Date: 03/01/2019
Terumo BCT's CEO David Perez may be retiring, but he isn't leaving the Colorado bioscience community. He sat down with the Denver Business Journal’s James Rodriguez to discuss his successes at Terumo...
Learn MoreSapphire Technology Completes a Nationwide Distribution Agreement With Burkhart Dental Supply
By: Colorado BioScience Association Date: 06/27/2018
Denver-based dental instrument company, Sapphire Technology, recently completed a nationwide distribution agreement with Burkhart Dental Supply (Tacoma, WA). Burkhart will soon market and sell Sapphir...
Learn More